148 related articles for article (PubMed ID: 29706525)
1. Structure-activity relationship of clovamide and its related compounds for the inhibition of amyloid β aggregation.
Tsunoda T; Takase M; Shigemori H
Bioorg Med Chem; 2018 Jul; 26(12):3202-3209. PubMed ID: 29706525
[TBL] [Abstract][Full Text] [Related]
2. Effects of clovamide and its related compounds on the aggregations of amyloid polypeptides.
Nomoto D; Tsunoda T; Shigemori H
J Nat Med; 2021 Mar; 75(2):299-307. PubMed ID: 33389592
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of catecholamine derivatives as amyloid-beta aggregation inhibitors.
Xu F; Takiguchi Y; Makabe K; Konno H
Bioorg Med Chem Lett; 2024 Jul; 107():129788. PubMed ID: 38740144
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory activities of kukoamines A and B from Lycii Cortex on amyloid aggregation related to Alzheimer's disease and type 2 diabetes.
Jiang G; Takase M; Aihara Y; Shigemori H
J Nat Med; 2020 Jan; 74(1):247-251. PubMed ID: 31267354
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant studies by hydrodynamic voltammetry and DFT, quantitative analyses by HPLC-DAD of clovamide, a natural phenolic compound found in Theobroma Cacao L. beans.
Ye N; Belli S; Caruso F; Roy G; Rossi M
Food Chem; 2021 Mar; 341(Pt 2):128260. PubMed ID: 33039740
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of amyloid β aggregation by acteoside, a phenylethanoid glycoside.
Kurisu M; Miyamae Y; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Biosci Biotechnol Biochem; 2013; 77(6):1329-32. PubMed ID: 23748773
[TBL] [Abstract][Full Text] [Related]
7. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Sato M; Murakami K; Uno M; Nakagawa Y; Katayama S; Akagi K; Masuda Y; Takegoshi K; Irie K
J Biol Chem; 2013 Aug; 288(32):23212-24. PubMed ID: 23792961
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activities of phenylpropanoids from Lycopus lucidus on amyloid aggregation related to Alzheimer's disease and type 2 diabetes.
Sun J; Murata T; Shigemori H
J Nat Med; 2020 Jun; 74(3):579-583. PubMed ID: 32219646
[TBL] [Abstract][Full Text] [Related]
10. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
11. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
[TBL] [Abstract][Full Text] [Related]
12. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Clovamide Analogues That Inhibit NO Production in Activated BV-2 Microglial Cells.
Park JY; Kim BW; Lee HU; Choi DK; Yoon SH
Biol Pharm Bull; 2017 Sep; 40(9):1475-1482. PubMed ID: 28592715
[TBL] [Abstract][Full Text] [Related]
15. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
Li X; Wang W; Dong X; Sun Y
J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
Lan JS; Hou JW; Liu Y; Ding Y; Zhang Y; Li L; Zhang T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):776-788. PubMed ID: 28585866
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
19. Activity-differential search for amyloid-β aggregation inhibitors using LC-MS combined with principal component analysis.
Hanaki M; Murakami K; Gunji H; Irie K
Bioorg Med Chem Lett; 2022 Apr; 61():128613. PubMed ID: 35176471
[TBL] [Abstract][Full Text] [Related]
20. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
